Sam Brusco, Associate Editor03.27.23
Exactech has exclusively licensed new software from Advata that will extend the capabilities of its machine learning (ML)-based Predict+ clinical decision support tool.
The newly licensed software will further facilitate Predict+ integration with the Equinoxe planning app and encourage integration with other software and databases.
Predict+ is a data-driven, clinical decision support tool and the first software of its type to use ML to create personalized risk-benefit analyses to predict outcomes after shoulder replacement surgery. The software was engineered to better inform surgeons on expected outcomes that can be achieved after shoulder arthroplasty, based on clinical experience documented in a single-shoulder prosthesis outcomes database of over 15,000 patients.
“Advata is proud of the productive research and development collaboration with Exactech over the past several years. With the help of Advata’s exclusively licensed software for orthopaedic applications, Exactech now hosts Predict+ and can steward the continued development of this innovative ML-based product. This licensed software will encourage new innovations and improvements in usability of Predict+ and other future applications,” Sudarshan Chitre, Advata’s chief technology officer told the press.
Exactech has also hired a team of machine learning researchers and engineers to further accelerate the company’s research and development capabilities and improve its ability to produce further AI-based software for various orthopedic applications.
“Exactech is leading the orthopedic industry in ML research and software applications.1-7 I am proud of Exactech’s vision to utilize enabling technologies with the goal of improving clinical outcomes and for making this investment to expand our in-house artificial intelligence capabilities,” said Chris Roche, Exactech’s senior VP of Extremities. “This investment in new software and the hiring of this amazing machine learning team will serve as a catalyst for even more powerful and predictive artificial intelligence research and development applications for the Equinoxe shoulder, and also for other Exactech hip, knee, and ankle products.”
“My team and I share Exactech’s vision that machine learning has the potential to transform healthcare decision making,” said Vikas Kumar, Exactech’s new VP of Machine Learning. “When paired with high quality healthcare data, novel ML applications will provide orthopaedic surgeons with valuable new data to help them make more informed, evidence-based decisions through which we aim to optimize clinical outcomes after arthroplasty. My team and I are proud of what we have developed with Exactech since 2019, and we are excited about what we will develop and deploy in the years to come at Exactech.”
The newly licensed software will further facilitate Predict+ integration with the Equinoxe planning app and encourage integration with other software and databases.
Predict+ is a data-driven, clinical decision support tool and the first software of its type to use ML to create personalized risk-benefit analyses to predict outcomes after shoulder replacement surgery. The software was engineered to better inform surgeons on expected outcomes that can be achieved after shoulder arthroplasty, based on clinical experience documented in a single-shoulder prosthesis outcomes database of over 15,000 patients.
“Advata is proud of the productive research and development collaboration with Exactech over the past several years. With the help of Advata’s exclusively licensed software for orthopaedic applications, Exactech now hosts Predict+ and can steward the continued development of this innovative ML-based product. This licensed software will encourage new innovations and improvements in usability of Predict+ and other future applications,” Sudarshan Chitre, Advata’s chief technology officer told the press.
Exactech has also hired a team of machine learning researchers and engineers to further accelerate the company’s research and development capabilities and improve its ability to produce further AI-based software for various orthopedic applications.
“Exactech is leading the orthopedic industry in ML research and software applications.1-7 I am proud of Exactech’s vision to utilize enabling technologies with the goal of improving clinical outcomes and for making this investment to expand our in-house artificial intelligence capabilities,” said Chris Roche, Exactech’s senior VP of Extremities. “This investment in new software and the hiring of this amazing machine learning team will serve as a catalyst for even more powerful and predictive artificial intelligence research and development applications for the Equinoxe shoulder, and also for other Exactech hip, knee, and ankle products.”
“My team and I share Exactech’s vision that machine learning has the potential to transform healthcare decision making,” said Vikas Kumar, Exactech’s new VP of Machine Learning. “When paired with high quality healthcare data, novel ML applications will provide orthopaedic surgeons with valuable new data to help them make more informed, evidence-based decisions through which we aim to optimize clinical outcomes after arthroplasty. My team and I are proud of what we have developed with Exactech since 2019, and we are excited about what we will develop and deploy in the years to come at Exactech.”